Last Updated: November 8, 2026

PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE Drug Patent Profile

Name: PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Prilocaine Hydrochloride And Epinephrine Bitartrate, and when can generic versions of Prilocaine Hydrochloride And Epinephrine Bitartrate launch?

Prilocaine Hydrochloride And Epinephrine Bitartrate is a drug marketed by Septodont Inc and is included in one NDA.

The generic ingredient in PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE is epinephrine bitartrate; prilocaine hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE?
What are the global sales for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE?
What is Average Wholesale Price for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE?

Summary for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	3
Patent Applications:	5
DailyMed Link:	PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE at DailyMed

Drug patent expirations by year for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Pharmacology for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

Drug Class	Amide Local Anesthetic Catecholamine alpha-Adrenergic Agonist beta-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Adrenergic beta-Agonists
Physiological Effect	Local Anesthesia

US Patents and Regulatory Information for PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Septodont Inc	PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE	epinephrine bitartrate; prilocaine hydrochloride	INJECTABLE;INJECTION	078959-001	Aug 30, 2011	AP	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.